207 related articles for article (PubMed ID: 36044788)
1. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
[TBL] [Abstract][Full Text] [Related]
3. Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.
Gaál A; Orgován G; Polgári Z; Réti A; Mihucz VG; Bősze S; Szoboszlai N; Streli C
J Inorg Biochem; 2014 Jan; 130():52-8. PubMed ID: 24176919
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro assessment of an anti-tumor nano-formulation.
Holley CK; Kang YJ; Kuo CF; Abidian MR; Majd S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110481. PubMed ID: 31539751
[TBL] [Abstract][Full Text] [Related]
5. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
6. Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy.
He W; Li X; Morsch M; Ismail M; Liu Y; Rehman FU; Zhang D; Wang Y; Zheng M; Chung R; Zou Y; Shi B
ACS Nano; 2022 Apr; 16(4):6293-6308. PubMed ID: 35353498
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake of the antitumor agent Dp44mT occurs via a carrier/receptor-mediated mechanism.
Merlot AM; Pantarat N; Menezes SV; Sahni S; Richardson DR; Kalinowski DS
Mol Pharmacol; 2013 Dec; 84(6):911-24. PubMed ID: 24085840
[TBL] [Abstract][Full Text] [Related]
8. Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.
Yuan J; Lovejoy DB; Richardson DR
Blood; 2004 Sep; 104(5):1450-8. PubMed ID: 15150082
[TBL] [Abstract][Full Text] [Related]
9. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.
Zou Y; Liu Y; Yang Z; Zhang D; Lu Y; Zheng M; Xue X; Geng J; Chung R; Shi B
Adv Mater; 2018 Dec; 30(51):e1803717. PubMed ID: 30328157
[TBL] [Abstract][Full Text] [Related]
10. Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines.
Shan T; Wang W; Fan M; Bi J; He T; Sun Y; Zheng M; Yan D
J Control Release; 2024 Jun; 370():866-878. PubMed ID: 38685386
[TBL] [Abstract][Full Text] [Related]
11. The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
Gutierrez E; Richardson DR; Jansson PJ
J Biol Chem; 2014 Nov; 289(48):33568-89. PubMed ID: 25301941
[TBL] [Abstract][Full Text] [Related]
12. The anticancer drug Dp44mT inhibits T-cell activation and CD25 through a copper-dependent mechanism.
Gundelach JH; Madhavan AA; Wettstein PJ; Bram RJ
FASEB J; 2013 Feb; 27(2):782-92. PubMed ID: 23134680
[TBL] [Abstract][Full Text] [Related]
13. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
Jansson PJ; Yamagishi T; Arvind A; Seebacher N; Gutierrez E; Stacy A; Maleki S; Sharp D; Sahni S; Richardson DR
J Biol Chem; 2015 Apr; 290(15):9588-603. PubMed ID: 25720491
[TBL] [Abstract][Full Text] [Related]
14. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
15. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
18. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.
Zou Y; Wang Y; Xu S; Liu Y; Yin J; Lovejoy DB; Zheng M; Liang XJ; Park JB; Efremov YM; Ulasov I; Shi B
Adv Mater; 2022 Aug; 34(33):e2203958. PubMed ID: 35738390
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.
Ishiguro K; Lin ZP; Penketh PG; Shyam K; Zhu R; Baumann RP; Zhu YL; Sartorelli AC; Rutherford TJ; Ratner ES
Biochem Pharmacol; 2014 Oct; 91(3):312-22. PubMed ID: 25130544
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and Optimization of Dp44mT-Loaded Nanoparticles.
Holley CK; Alkhalifah S; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5733-5736. PubMed ID: 30441638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]